Literature DB >> 18382890

Homocysteine toxicity in connective tissue: theories, old and new.

John I Toohey1.   

Abstract

Hyperhomocysteinemia causes connective tissue pathology. Several theories on the mechanism of homocysteine toxicity in connective tissue are reviewed briefly. A possible new mechanism was revealed recently in the discovery of a reaction in which homocysteine thiolactone is converted to mercaptopropionaldehyde. The reaction is the Strecker degradation of amino acids in which ninhydrin is replaced by the structurally similar dehydroascorbic acid. The reaction may occur in vivo and may be pathogenic to connective tissue in four ways: (1) the reaction may deplete ascorbic acid that is required for collagen synthesis, (2) the mercaptoaldehyde product may interfere with collagen synthesis, (3) the mercaptoaldehyde may cause abnormal cross-linking of collagen molecules, and (4) the mercaptoaldehyde may attach to collagen molecules rendering them antigenic and triggering an autoimmune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382890     DOI: 10.1080/03008200801913742

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  4 in total

1.  Plasma Homocysteine is a Predictive Factor for Arterial Stiffness: A Community-Based 4.8-Year Prospective Study.

Authors:  Xiao-Na Wang; Ping Ye; Rui-Hua Cao; Xu Yang; Wen-Kai Xiao; Yun Zhang; Yong-Yi Bai; Hong-Mei Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-04-20       Impact factor: 3.738

2.  Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases.

Authors:  Necat Yilmaz
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

3.  Proteomic and systems biology analysis of the monocyte response to Coxiella burnetii infection.

Authors:  Matt Shipman; Kirk Lubick; David Fouchard; Rajani Gurram; Paul Grieco; Mark Jutila; Edward A Dratz
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

4.  A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritis.

Authors:  Piet Geusens; Karel Pavelka; Jozef Rovensky; Johan Vanhoof; Nathalie Demeester; Mario Calomme; Dirk Vanden Berghe
Journal:  BMC Musculoskelet Disord       Date:  2017-01-05       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.